UB Paderborn / Katalog / Suche / in CDI

1 – 22 von 22

Sortiert nach

Medications development for the treatment of alcohol use disorder: insights into the predictive value of animal and human laboratory models

Addiction biology, 2017-05, Vol.22 (3), p.581-615

2017

Volltextzugriff (PDF)

Review: Pharmacogenetics of alcoholism treatment: Implications of ethnic diversity

The American journal on addictions, 2017-08, Vol.26 (5), p.516-525

2017

Volltextzugriff (PDF)

Differences between treatment-seeking and non-treatment-seeking participants in medication studies for alcoholism: do they matter?

The American journal of drug and alcohol abuse, 2017-11, Vol.43 (6), p.703-710

2017

Volltextzugriff (PDF)

Ivermectin reduces alcohol intake and preference in mice

Neuropharmacology, 2012-08, Vol.63 (2), p.190-201

2012

Volltextzugriff (PDF)

Contribution of P2X4 Receptors to Ethanol Intake in Male C57BL/6 Mice

Neurochemical research, 2014-06, Vol.39 (6), p.1127-1139

2014

Volltextzugriff (PDF)

Pharmacological Options for Smoking Cessation in Heavy-Drinking Smokers

CNS drugs, 2015-10, Vol.29 (10), p.833-845

2015

Volltextzugriff (PDF)

A Pilot Study of the Safety and Initial Efficacy of Ivermectin for the Treatment of Alcohol Use Disorder

Alcoholism, clinical and experimental research, 2016-06, Vol.40 (6), p.1312-1320

2016

Volltextzugriff (PDF)

Multiday administration of ivermectin is effective in reducing alcohol intake in mice at doses shown to be safe in humans

Neuroreport, 2014-09, Vol.25 (13), p.1018-1023

2014

Volltextzugriff (PDF)

Pharmacological insights into the role of P2X4 receptors in behavioural regulation: lessons from ivermectin

The international journal of neuropsychopharmacology, 2013-06, Vol.16 (5), p.1059-1070

2013

Volltextzugriff (PDF)

Oral delivery of ivermectin using a fast dissolving oral film: Implications for repurposing ivermectin as a pharmacotherapy for alcohol use disorder

Alcohol (Fayetteville, N.Y.), 2015-09, Vol.49 (6), p.553-559

2015

Volltextzugriff (PDF)

Avermectins differentially affect ethanol intake and receptor function: implications for developing new therapeutics for alcohol use disorders

The international journal of neuropsychopharmacology, 2014-06, Vol.17 (6), p.907-916

2014

Volltextzugriff (PDF)

Current Insights into the Mechanisms and Development of Treatments for Heavy-Drinking Cigarette Smokers

Current addiction reports, 2016-03, Vol.3 (1), p.125-137

2016

Volltextzugriff (PDF)

Pharmacogenetics of alcoholism treatment: Implications of ethnic diversity

The American journal on addictions, 2016-11, Vol.26 (5), p.516-525

2016

Volltextzugriff (PDF)

Multi-Day Administration of Ivermectin is Effective in Reducing Alcohol Intake in Mice at Doses Shown to be Safe in Humans

Neuroreport, 2014-09, Vol.25 (13), p.1018-1023

2014

Volltextzugriff (PDF)

Pharmacological insights into the role of P2X sub(4) receptors in behavioural regulation: lessons from ivermectin

The international journal of neuropsychopharmacology, 2013-06, Vol.16 (5), p.1059-1070

2013

Volltextzugriff (PDF)

Development of Ivermectin as a Platform for the Treatment and/or Prevention of Alcohol Use Disorders

Yardley, Megan M

2014

Volltextzugriff (PDF)

Integrating Psychological and Pharmacological Treatments for Addictive Disorders: An Evidence-Based Guide

First edition., 2018

Volltextzugriff (PDF)

Addiction Treatment in Primary Care

Integrating Psychological and Pharmacological Treatments for Addictive Disorders, 2018, p.221-229

1, 2018

Volltextzugriff (PDF)

Training Challenges and Opportunities amid the COVID-19 Pandemic: Perspectives From Pediatric Psychology Interns

Clinical practice in pediatric psychology, 2022-03, Vol.10 (1), p.91-98

2022

Volltextzugriff (PDF)

Further delineation of short-chain enoyl-CoA hydratase deficiency in the Pacific population

Molecular genetics and metabolism, 2024-07, Vol.142 (3), p.108508, Article 108508

2024

Volltextzugriff (PDF)

Phase I Study of Paclitaxel Given by Seven-Week Continuous Infusion Concurrent with Radiation Therapy for Locally Advanced Non–Small Cell Lung Cancer

Journal of thoracic oncology, 2006-01, Vol.1 (1), p.38-45

2006

Volltextzugriff (PDF)

Phase I Study of Paclitaxel Given by Seven-Week Continuous Infusion Concurrent with Radiation Therapy for Locally Advanced Non–Small Cell Lung Cancer

Journal of thoracic oncology, 2006-01, Vol.1 (1), p.38-45

2006

Volltextzugriff (PDF)

1 – 22 von 22

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(18)
Mit Volltextzugriff
(21)

Publikationsform

Sprache

Englisch
(22)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Medications development for the treatment of alcohol use disorder: insights into the predictive value of animal and human laboratory models

Review: Pharmacogenetics of alcoholism treatment: Implications of ethnic diversity

Differences between treatment-seeking and non-treatment-seeking participants in medication studies for alcoholism: do they matter?

Ivermectin reduces alcohol intake and preference in mice

Contribution of P2X4 Receptors to Ethanol Intake in Male C57BL/6 Mice

Pharmacological Options for Smoking Cessation in Heavy-Drinking Smokers

A Pilot Study of the Safety and Initial Efficacy of Ivermectin for the Treatment of Alcohol Use Disorder

Multiday administration of ivermectin is effective in reducing alcohol intake in mice at doses shown to be safe in humans

Pharmacological insights into the role of P2X4 receptors in behavioural regulation: lessons from ivermectin

Oral delivery of ivermectin using a fast dissolving oral film: Implications for repurposing ivermectin as a pharmacotherapy for alcohol use disorder

Avermectins differentially affect ethanol intake and receptor function: implications for developing new therapeutics for alcohol use disorders

Current Insights into the Mechanisms and Development of Treatments for Heavy-Drinking Cigarette Smokers

Pharmacogenetics of alcoholism treatment: Implications of ethnic diversity

Multi-Day Administration of Ivermectin is Effective in Reducing Alcohol Intake in Mice at Doses Shown to be Safe in Humans

Pharmacological insights into the role of P2X sub(4) receptors in behavioural regulation: lessons from ivermectin

Development of Ivermectin as a Platform for the Treatment and/or Prevention of Alcohol Use Disorders

Integrating Psychological and Pharmacological Treatments for Addictive Disorders: An Evidence-Based Guide

Addiction Treatment in Primary Care

Training Challenges and Opportunities amid the COVID-19 Pandemic: Perspectives From Pediatric Psychology Interns

Further delineation of short-chain enoyl-CoA hydratase deficiency in the Pacific population

Phase I Study of Paclitaxel Given by Seven-Week Continuous Infusion Concurrent with Radiation Therapy for Locally Advanced Non–Small Cell Lung Cancer

Phase I Study of Paclitaxel Given by Seven-Week Continuous Infusion Concurrent with Radiation Therapy for Locally Advanced Non–Small Cell Lung Cancer

Suchergebnisse filtern